Rigshospitalet
Copenhagen, Denmark
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This clinical trial is focused on improving pain management for patients who have undergone heart surgery, specifically coronary artery bypass grafting and/or valve surgery. After such surgeries, patients often experience significant pain and require high amounts of pain-relieving medications, which can lead to negative side effects and poor recovery outcomes. The study aims to compare the effectiveness of a single dose of methadone given during surgery with the usual care, which involves the use of fentanyl and oxycodone, in reducing the need for additional pain medication after surgery.
Participants in the study will receive one of the treatments during their surgery. The study will monitor the amount of pain medication needed after surgery, as well as other factors like pain levels, recovery time, and overall quality of life. The trial will also look at how quickly patients can be discharged from the hospital and any complications that may arise, such as irregular heartbeats or delayed bowel function.
The goal of this research is to find the most effective way to manage pain after heart surgery, which could lead to better recovery experiences for patients. By comparing methadone with the more commonly used fentanyl and oxycodone, the study hopes to identify a treatment that reduces the need for additional pain medication and improves overall patient outcomes.
The trial runs in 6 steps – from screening to follow-up. Each step says what happens and what the team monitors.
4 criteria
5 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Copenhagen, Denmark
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
is being tested in this trial to see if it can help reduce the need for other pain medications after surgery. It is given as a single dose during the operation, right after the patient is put under anesthesia. The goal is to see if this approach can effectively manage pain after heart surgery.
is used as part of the usual care for managing pain during and after surgery. In this trial, it is given during the operation to help control pain. The study is comparing its effectiveness to methadone.
is another medication used in the usual care for pain management in this trial. It is administered during the operation to help reduce pain. The trial aims to compare its effectiveness with methadone in managing post-operative pain.
Methadone is administered as a single dose during surgery, specifically after anesthesia is induced. It is currently being studied in clinical trials to assess its effectiveness in reducing postoperative pain and opioid consumption in patients undergoing heart surgery. Methadone is primarily used for pain management and opioid addiction treatment. It works by binding to opioid receptors in the brain, altering the perception of pain and providing relief. Methadone is classified as an opioid analgesic.
Fentanyl is typically administered during surgery to manage pain, often as part of the standard care for patients undergoing heart surgery. It is a well-established medication in medical practice, known for its potent pain-relieving properties. Fentanyl acts by binding to opioid receptors in the brain, providing significant pain relief. It is classified as an opioid analgesic.
Oxycodone is administered during surgery to help control pain, commonly used alongside other medications like fentanyl. It is widely recognized in medical literature for its effectiveness in managing moderate to severe pain. Oxycodone works by binding to opioid receptors in the central nervous system, altering the body's response to pain. It is classified as an opioid analgesic.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.